BRAGF yields 32.79% · JNJ yields 2.13%● Live data
📍 JNJ pulled ahead of the other in Year 9
Combined, BRAGF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of BRAGF + JNJ for your $10,000?
BAUER Aktiengesellschaft, together with its subsidiaries, provides services, equipment, and products related to ground and groundwater in Germany and internationally. It operates through three segments: Construction, Equipment, and Resources. The Construction segment engages in the foundation engineering activities. This segment also offers services for excavation pits, as well as foundations for infrastructure projects and buildings, cut-off walls, and ground improvement. The Equipment segment provides equipment for exploration, mining, and exploitation of natural resources. This segment also designs and builds heavy-duty drilling rigs, trench cutters, grab systems, vibrators, and deep drilling rigs, as well as related tools. The Resources segment provides products and services for drilling services and water wells, environmental services, constructed wetlands, and mining and remediation. BAUER Aktiengesellschaft was founded in 1790 and is headquartered in Schrobenhausen, Germany.
Full BRAGF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.